FDA halts recruitment to three BMS Opdivo trials
FDA is investigating safety of immunotherapies in blood cancer.
X
FDA halts recruitment to three BMS Opdivo trials
https://pharmaphorum.com/news/fda-halts-recruitment-three-bms-opdivo-trials/
safety
FDA probes blood cancer immunotherapy safety
Regulator reviewing combination therapy safety after issue with Keytruda
J&J speaks out as old drug included in lethal injection
State of Florida to use untried cocktail in execution of Mark Asay
J&J to pay $417m in talc cancer case
J&J to appeal California court’s verdict
US opioid crisis a ‘national emergency’, says Trump
Declaration means potential more resources and power to states and federal agencies.
FDA advisers reject J&J rheumatoid arthritis drug
Expert panel concerned about safety of sirukumab.